These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
250 related items for PubMed ID: 17678997
1. Interferon beta in multiple sclerosis: how much BENEFIT? Pittock SJ. Lancet; 2007 Aug 04; 370(9585):363-4. PubMed ID: 17678997 [No Abstract] [Full Text] [Related]
2. Interferon beta-1b (Extavia) for multiple sclerosis. Med Lett Drugs Ther; 2010 Nov 01; 52(1350):86-7. PubMed ID: 21045760 [No Abstract] [Full Text] [Related]
3. Interferon-beta for multiple sclerosis: Long-term benefits? Rudick RA, Cutter G. Ann Neurol; 2007 Apr 01; 61(4):283-5. PubMed ID: 17444503 [No Abstract] [Full Text] [Related]
4. Use of interferon-beta in the treatment of multiple sclerosis. Derwenskus J, Lublin FD. Adv Neurol; 2006 Apr 01; 98():257-71. PubMed ID: 16400838 [No Abstract] [Full Text] [Related]
5. [Logistics and description of treatment technology (the protocol for using disease modifying drugs--DMD)]. Federal service on surveillance in healthcare and social development (Roszdravnadzor). Zh Nevrol Psikhiatr Im S S Korsakova; 2011 Apr 01; 111(2 Pt 2):93-8. PubMed ID: 21916163 [No Abstract] [Full Text] [Related]
6. Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study. Kappos L, Freedman MS, Polman CH, Edan G, Hartung HP, Miller DH, Montalbán X, Barkhof F, Radü EW, Bauer L, Dahms S, Lanius V, Pohl C, Sandbrink R, BENEFIT Study Group. Lancet; 2007 Aug 04; 370(9585):389-97. PubMed ID: 17679016 [Abstract] [Full Text] [Related]
7. Multiple sclerosis: interferon beta for some serious forms. Prescrire Int; 2007 Dec 04; 16(92):252-7. PubMed ID: 18092425 [Abstract] [Full Text] [Related]
8. [Beta interferon and multiple sclerosis]. Kinnunen E. Duodecim; 1996 Dec 04; 112(24):2368-73. PubMed ID: 10605237 [No Abstract] [Full Text] [Related]
9. 'Time is brain' also in multiple sclerosis. Freedman MS. Mult Scler; 2009 Oct 04; 15(10):1133-4. PubMed ID: 19808740 [No Abstract] [Full Text] [Related]
10. [Interferon therapy of multiple sclerosis. Synopsis of various dosage forms]. Jarius S, Hohlfeld R. Nervenarzt; 2004 Dec 04; 75(12):1226-30. PubMed ID: 15565383 [Abstract] [Full Text] [Related]
11. The use of interferon Beta and glatiramer acetate in multiple sclerosis. Goodin DS. Semin Neurol; 2013 Feb 04; 33(1):13-25. PubMed ID: 23709209 [Abstract] [Full Text] [Related]
12. Interferon beta-1a and beta-1b for treatment of multiple sclerosis. Benatar M. Lancet; 2002 Nov 02; 360(9343):1428; author reply 1428-9. PubMed ID: 12424021 [No Abstract] [Full Text] [Related]
13. Unmasking of autoimmune hepatitis in a patient with MS following interferon beta therapy. Pulicken M, Koteish A, DeBusk K, Calabresi PA. Neurology; 2006 Jun 27; 66(12):1954-5. PubMed ID: 16801674 [No Abstract] [Full Text] [Related]
14. Confounders in natural history of interferon-beta-treated relapsing multiple sclerosis. Gout O. Ann Neurol; 2008 Jan 27; 63(1):126; author reply 126-7. PubMed ID: 17702028 [No Abstract] [Full Text] [Related]
15. Interferon beta failure predicted by EMA criteria or isolated MRI activity in multiple sclerosis. Prosperini L, Mancinelli CR, De Giglio L, De Angelis F, Barletta V, Pozzilli C. Mult Scler; 2014 Apr 27; 20(5):566-76. PubMed ID: 23999607 [Abstract] [Full Text] [Related]
16. Glatiramer and suspected multiple sclerosis. No proven advantage. Prescrire Int; 2010 Aug 27; 19(108):160. PubMed ID: 20941852 [No Abstract] [Full Text] [Related]